Projects
34
Outputs
19
Publications
19
OA Rate
100.0%
Number of FWF projects approved by year at this institution
Publications vs. other research outputs (pre-computed)
| PI Name | Projects |
|---|---|
| Christoph Bock | 6 |
| Florian Grebien | 4 |
| Stefan Kubicek | 4 |
| Giulio Gino Maria Superti-Furga | 4 |
| Abdel Rahman Abdel Fattah | 2 |
| Barbara Maier | 2 |
| Laura De Rooij | 2 |
| Title | Year | Status | Outputs |
|---|---|---|---|
| Metabolic adaptation during helminth infection | 2026 | Ongoing | 0 |
| Metabolic engineering for optimization of CAR T cell therapy | 2026 | Ongoing | 0 |
| Megan Teh | 1 |
| Wentao Li | 1 |
| Ann-Katrin Hopp | 1 |
| Transporters as platform for metabolic sensing and signaling | 2026 | Pending | 0 |
| MagBioPrint: Bioprinting immune cell constructs with magnets | 2026 | Pending | 0 |
| PharmacogenOmics to Optimize Steroid Treatment in Children | 2025 | Ongoing | 0 |
| Small-molecule-mediated targeting of oncogenic condensates | 2025 | Ongoing | 0 |
| Nuclear One Carbon Metabolism | 2025 | Ongoing | 0 |
| Lymph node myeloid cells directing anti-tumor T cell priming | 2025 | Ongoing | 0 |
| HAVOC | 2025 | Ongoing | 0 |
| Visual Proteomics for studying subcellular protein dynamics | 2024 | Ongoing | 1 |
| Traumatoids: Modeling traumatic brain injury with organoids | 2024 | Ongoing | 1 |
| PROMISE: Personalized Therapy for Immune-linked Disorders | 2024 | Ongoing | 0 |
| Point of Contact: Pinpointing Small Molecule-Protein Binding | 2024 | Ongoing | 1 |
| Mutant-selective proteolytic logic of EGFR | 2023 | Ended | 4 |
| Enhancing T cell immunity in tumor-draining lymph nodes | 2023 | Ongoing | 0 |
| Circulating Endothelial Cells as Vascular Aging Sensors | 2023 | Ongoing | 1 |
| Oncogenic biomolecular condensation in NUP98-fusion leukemia | 2021 | Ongoing | 3 |
| Systematic Evaluation of ABC Transporters in Leukemia | 2021 | Ended | 5 |
| METALGATES - Transporters as mediators of metal toxicity | 2021 | Ongoing | 1 |
| Non-coding RNAs in oncogene-induced biomolecular condensates | 2021 | Ended | 0 |
| Resetting the Epigenetic Status of the DM1 Locus | 2020 | Ended | 2 |
| The Human Mini-Cell | 2020 | Ended | 0 |
| Multi-Omics Analyse des Antikörpermangelsyndroms (i-PAD) | 2018 | Ended | 0 |
| Mechanism of CALR mutants in Myeloproliferative Neoplasms | 2017 | Ended | 0 |
| The viral transportome (ViTra) | 2016 | Ended | 0 |
| Cancer evolution and identification of relapse-initiating cells (CEVIR) | 2015 | Ended | 0 |
| Evaluating viral RNA/DNA-bound proteins Across SpeciEs (ERASE) | 2014 | Ended | 0 |
| Identifying suppressors of DNA damage hypersensitivity | 2014 | Withdrawn | 0 |
| Epigenetic risk assessment and biomarker development for breast cancer (EpiMark) | 2013 | Ended | 0 |
| Co-Infection as a caus of ovarian cancer (CINOCA) | 2013 | Ended | 0 |
Showing 30 of 34 projects. View all →